Hi, How Are You?
↻
Let's Get Started
Forgot Password?
Sign Up
EN
Home
Article
Events
All Events
Webinar
new!
Product & Disease
Product
Disease
Pharmacovigilance
Medical Calculator
new!
Education
MOOC
CDK
Multimedia
FAQ & Feedback
Discussions
About Us
Login
Register
Product
Profile
PRODUCTS
DISEASE
PHARMACOVIGILANCE
MEDCAL
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
TERASTARCH
BRANDED
Terastarch 60 mg/mL is a colloidal plasma volume substitute containing 6% Hydroxyethyl starch (HES) in a balanced electrolyte solution. The mean molecular weight is 130,000 Daltons and its molar substitution is 0.42.
Available at :
Share this article
Related
Articles
Hantavirus Infection: A Zoonotic Disease from Rats That Should Be Taken Seriously
by dr. Dita Arccinirmala | 08 May 2026
Neoadjuvant Fulvestrant Yields Equal Effectiveness and Tolerability to Anastrozole
by dr. Johan Indra Lukito | 17 Mar 2026
Immunotherapy Plus Chemotherapy Improves Clinical Outcomes in Advanced Lung Cancer Study
by dr. Farica Noviana Kartawijaya | 25 Feb 2026
Significant Improvement in Advanced Breast Cancer Therapy with the Addition of Palbociclib
by dr. Johan Indra Lukito | 16 Feb 2026
Combination of Maltodextrin and Early Enteral Nutrition Accelerates Recovery in Colorectal Cancer Patients
by dr. Dedyanto Henky Saputra, M.Gizi, AIFO-K | 11 Feb 2026
Nipah Virus Disease: Symptoms and Prevention
by dr. Dita Arccinirmala | 02 Feb 2026
Fludeoxyglucose F18 (FDG) PET Scan: An Important Imaging Test in Cancer Diagnosis and Treatment
by dr. Farica Noviana Kartawijaya | 26 Jan 2026
Early Oral Nutritional Supplements for Gastrointestinal Cancer Patients: Here Are the Benefits
by dr. Dedyanto Henky Saputra, M.Gizi | 16 Jan 2026
Osimertinib Plus Chemotherapy: Better Survival in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations
by dr. Johan Indra Lukito | 14 Jan 2026
Pregabalin Administration Reduces the Severity of Neuropathic Pain in Head and Neck Cancer Patients Undergoing Radiotherapy
by dr. Hastarita Lawrenti | 22 Dec 2025
×
Subscribe Status
Generals
Articles
CPD/CME & CDK
Events & Webinar
SAVE